chr11-17634950-T-C
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_001292063.2(OTOG):c.7585+2T>C variant causes a splice donor, intron change. The variant allele was found at a frequency of 0.00000216 in 1,386,508 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: 𝑓 0.0000075 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000016 ( 0 hom. )
Consequence
OTOG
NM_001292063.2 splice_donor, intron
NM_001292063.2 splice_donor, intron
Scores
5
1
1
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 4.99
Genes affected
OTOG (HGNC:8516): (otogelin) The protein encoded by this gene is a component of the acellular membranes of the inner ear. Disruption of the orthologous mouse gene shows that it plays a role in auditory and vestibular functions. It is involved in fibrillar network organization, the anchoring of otoconial membranes and cupulae to the neuroepithelia, and likely in sound stimulation resistance. Mutations in this gene cause autosomal recessive nonsyndromic deafness, type 18B. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.011896592 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 11-17634950-T-C is Pathogenic according to our data. Variant chr11-17634950-T-C is described in ClinVar as [Likely_pathogenic]. Clinvar id is 505310.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOG | NM_001292063.2 | c.7585+2T>C | splice_donor_variant, intron_variant | ENST00000399397.6 | NP_001278992.1 | |||
OTOG | NM_001277269.2 | c.7621+2T>C | splice_donor_variant, intron_variant | NP_001264198.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOG | ENST00000399397.6 | c.7585+2T>C | splice_donor_variant, intron_variant | 5 | NM_001292063.2 | ENSP00000382329.2 | ||||
OTOG | ENST00000399391.7 | c.7621+2T>C | splice_donor_variant, intron_variant | 5 | ENSP00000382323.2 | |||||
OTOG | ENST00000342528.2 | n.4606-660T>C | intron_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000749 AC: 1AN: 133458Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
1
AN:
133458
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00000160 AC: 2AN: 1253050Hom.: 0 Cov.: 35 AF XY: 0.00000161 AC XY: 1AN XY: 621156
GnomAD4 exome
AF:
AC:
2
AN:
1253050
Hom.:
Cov.:
35
AF XY:
AC XY:
1
AN XY:
621156
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000749 AC: 1AN: 133458Hom.: 0 Cov.: 31 AF XY: 0.0000155 AC XY: 1AN XY: 64350
GnomAD4 genome
AF:
AC:
1
AN:
133458
Hom.:
Cov.:
31
AF XY:
AC XY:
1
AN XY:
64350
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Rare genetic deafness Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 06, 2016 | The c.7621+2T>C variant in OTOG has not been previously reported in individuals with hearing loss. Data from large population studies is insufficient to assess the frequency of this variant. This variant occurs in the invariant region (+/- 1,2) of the splice consensus sequence and is predicted to cause altered splicin g leading to an abnormal or absent protein. Two loss of function variants in the OTOG gene have been reported to segregate with hearing loss in two families (Sc hraders 2012), and disruption of Otog in mice resulted in deafness supporting of a loss-of-function mechanism for the disease (Simmler 2000). In summary, althou gh additional evidence is required to strengthen the gene-disease association be tween OTOG and hearing loss, currently available data support that the c.7621+2T >C variant is likely pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at